Epidemiological characteristics and medical follow-up of 61 patients with acute hepatitis C identified through the hepatitis C surveillance system in France.
This study aimed to describe current epidemiological and clinical characteristics, medical follow-up and outcome in the real practice of acute hepatitis C (AHC) patients. AHC cases were retrospectively identified through the French Hepatology Reference Centres Surveillance system and additional data were collected. Sixty-one patients with AHC were identified (sex ratio: M/F 1.7/1; mean age 39 years). Forty-four (72%) had documented seroconversion within a 6-month period. Main reported risk exposures were intravenous or nasal drug use (35%), invasive medical procedures (25%) and sexual contact with a HCV-positive partner (20%). Spontaneous clearance of HCV RNA was observed in seven out of 16 patients followed without therapy. This study confirms the major role of drug use in HCV transmission and highlights the role of invasive medical procedures and occupational exposure.
Brouard
C
C
Institut de Veille Sanitaire, Département des Maladies Infectieuses, Saint-Maurice Cedex, France. c.brouard@invs.sante.fr
Pradat
P
P
Delarocque-Astagneau
E
E
Silvain
C
C
D000328:Adult; D000368:Aged; D005260:Female; D005602:France / Q000453:epidemiology; D006526:Hepatitis C / Q000453:epidemiology* / Q000276:immunology / Q000503:physiopathology* / Q000635:transmission; D006801:Humans; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000097:blood; D012307:Risk Factors; D012698:Serologic Tests; D019966:Substance-Related Disorders / Q000150:complications; D013514:Surgical Procedures, Operative / Q000009:adverse effects
D012367:RNA, Viral
J Hepatol. 2001 Aug;35(2):284-9
11580153
Hepatology. 1999 Mar;29(3):908-14
10051497
J Gastroenterol Hepatol. 2004 Mar;19(3):283-8
14748875
Gastroenterol Clin Biol. 2003 Jun;27(6-7):596-604
12910223
Am J Gastroenterol. 2004 May;99(5):855-9
15128350
Hepatology. 2002 Nov;36(5 Suppl 1):S21-9
12407573
N Engl J Med. 1992 Dec 31;327(27):1899-905
1280771
Infect Control Hosp Epidemiol. 2001 Nov;22(11):701-7
11842991
Hepatology. 2000 Mar;31(3):756-62
10706569
Infect Control Hosp Epidemiol. 2002 Jun;23(6):328-34
12083237
Hepatology. 2004 May;39(5):1213-9
15122749
Hepatology. 2006 Feb;43(2):221-4
16440365
Presse Med. 2005 Aug 27;34(14):1034-8
16225259
Hepatology. 2003 Jan;37(1):60-4
12500189
J Viral Hepat. 2005 Jul;12(4):405-13
15985012
Gastroenterol Clin Biol. 2002 Nov;26(11):994-1000
12483131
Hepatology. 2002 Oct;36(4 Pt 1):993-1000
12297849
N Engl J Med. 1997 Jul 24;337(4):237-40
9227929
Scand J Infect Dis. 2006;38(6-7):482-9
16798699
Rev Epidemiol Sante Publique. 2006 Jul;54 Spec No 1:1S5-1S14
17073125
Infect Control Hosp Epidemiol. 2005 Sep;26(9):789-92
16209386
Gastroenterology. 2003 Jul;125(1):80-8
12851873
N Engl J Med. 2001 Nov 15;345(20):1452-7
11794193
Hepatology. 2004 May;39(5):1201-3
15122747
J Hepatol. 1999;31 Suppl 1:88-91
10622567
Ann Intern Med. 2005 Jun 7;142(11):903-9
15941697
Hepatology. 2001 Feb;33(2):321-7
11172332
Dig Liver Dis. 2003 Feb;35(2):104-13
12747629
Gastroenterol Clin Biol. 2003 Mar;27(3 Pt  1):294-9
12700516
Euro Surveill. 2005 May;10(5):3-4
29183542
Gastroenterol Clin Biol. 2002 Apr;26 Spec No 2:B5-6
12180308
Am J Gastroenterol. 1999 May;94(5):1341-6
10235216
N Engl J Med. 1999 Aug 19;341(8):556-62
10451460
J Med Virol. 1999 Feb;57(2):111-3
9892393